Overview

Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults

Status:
Completed

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this Venlafaxine-referenced study is to evaluate the efficacy, safety and tolerability of two fixed doses of Vortioxetine in the acute treatment of Major Depressive Disorder (MDD).

Phase:

Phase 2

Details

Lead Sponsor:

H. Lundbeck A/S

Treatments:

Venlafaxine Hydrochloride
Vortioxetine